类人猿
发表于 2025-3-26 23:20:13
http://reply.papertrans.cn/29/2832/283195/283195_31.png
共同生活
发表于 2025-3-27 03:36:02
http://reply.papertrans.cn/29/2832/283195/283195_32.png
Vertebra
发表于 2025-3-27 06:12:22
http://reply.papertrans.cn/29/2832/283195/283195_33.png
meditation
发表于 2025-3-27 13:17:32
http://reply.papertrans.cn/29/2832/283195/283195_34.png
蒸发
发表于 2025-3-27 17:00:25
Daniel B. Cornfield,Randy Hodsonease has long been regarded as very unlikely to be successful. In 2002 the first report was published in a case series of five patients that advocated B cells as a therapeutic target, spurred by a report of Takemura et al., who even suggested that the activation of T cells in the rheumatoid synovium was B cell-dependent.
Duodenitis
发表于 2025-3-27 18:49:34
http://reply.papertrans.cn/29/2832/283195/283195_36.png
矛盾心理
发表于 2025-3-28 00:30:11
http://reply.papertrans.cn/29/2832/283195/283195_37.png
cuticle
发表于 2025-3-28 04:01:11
Building an International Sociology of Workditions such as steroid-resistant and dependent sarcoidosis, Behçet disease with retinal vasculitis, chronic hepatitis C virus-associated polyarteritis nodosa, highly active refractory Takayasu arteritis, and Henoch–Schönlein purpura nephritis.
Outwit
发表于 2025-3-28 06:35:04
B-Cell Targeted Therapies in Rheumatoid Arthritis,ease has long been regarded as very unlikely to be successful. In 2002 the first report was published in a case series of five patients that advocated B cells as a therapeutic target, spurred by a report of Takemura et al., who even suggested that the activation of T cells in the rheumatoid synovium was B cell-dependent.
蘑菇
发表于 2025-3-28 11:21:05
,B-Cell Targeted Therapies in Primary Sjögren Syndrome,the evidence from controlled trials has suggested that tumour necrosis factor blockers are not efficacious in primary SS, the use of B-cell targeted agents (rituximab, epratuzumab, belimumab) may be more promising therapies. However, the potential risks and benefits of these new agents must be always weighted carefully.